American Century Companies Inc Puma Biotechnology, Inc. Transaction History

American Century Companies Inc

$160 Billion
Q2 2024

A detailed history of American Century Companies Inc transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 738,902 shares of PBYI stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

738,902

Previous 372,249 98.5%

Holding current value

$1.91 Million

Previous $1.97 Million 22.11%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$2.92 - $5.83 $1.07 Million - $2.14 Million	366,653 Added 98.5%	738,902 $2.41 Million
Q1 2024 May 14, 2024	BUY	$4.29 - $7.4 $1.34 Million - $2.3 Million	311,197 Added 509.72%	372,249 $1.97 Million
Q4 2023 Feb 13, 2024	BUY	$2.23 - $4.49 $136,145 - $274,123	61,052 New	61,052 $264,000
Q3 2019 Nov 13, 2019	SELL	$8.75 - $12.85 $894,932 - $1.31 Million	-102,278 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$12.3 - $35.76 $247,377 - $719,205	20,112 Added 24.48%	102,278 $1.3 Million
Q1 2019 May 14, 2019	BUY	$20.77 - $42.37 $1.27 Million - $2.59 Million	61,018 Added 288.53%	82,166 $0
Q4 2018 Feb 13, 2019	SELL	$20.07 - $46.7 $1.14 Million - $2.64 Million	-56,635 Reduced 72.81%	21,148 $430,000
Q3 2018 Nov 02, 2018	BUY	$41.2 - $59.85 $963,832 - $1.4 Million	23,394 Added 43.01%	77,783 $3.57 Million
Q2 2018 Aug 08, 2018	BUY	$48.3 - $68.25 $503,479 - $711,438	10,424 Added 23.71%	54,389 $3.22 Million
Q1 2018 May 03, 2018	BUY	$59.7 - $99.25 $365,662 - $607,906	6,125 Added 16.19%	43,965 $2.99 Million
Q4 2017 Feb 02, 2018	SELL	$93.85 - $132.45 $1.33 Million - $1.87 Million	-14,144 Reduced 27.21%	37,840 $3.74 Million
Q3 2017 Nov 01, 2017	BUY	$72.0 - $119.75 $3.74 Million - $6.23 Million	51,984	51,984 $6.23 Million

Others Institutions Holding PBYI

# of Institutions

Shares Held

30.5M

Call Options Held

73.5K

Put Options Held

18.5K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $118M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Puma Biotechnology, Inc. Transaction History